Clinical Trial Update: A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women [Phase 2]

View source ↗

Summary

Phase 2 study assessing the effects of RCN3028 on moderate to severe vasomotor symptoms in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Premenstrual Syndrome

Drugs mentioned

• RCN3028

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: PMS, Hot Flashes | Phase 2 | Status: COMPLETED